More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$41.90B
P/E ratio
23.9
Dividend yield
1.6004%
Expense ratio
0.08%
Beta
0.613755
Previous close
$156.82
Today's open
$157.13
Day's range
$157.13 - $158.68
52 week range
$127.35 - $160.59
Industries
Health
14.46%
10.2%
XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500
Healthcare isn't going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions.
24/7 Wall Street • Feb 18, 2026

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
The State Street Health Care Select Sector SPDR ETF ETF (XLV) was launched on December 16, 1998, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
Zacks Investment Research • Feb 17, 2026

Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.
The Motley Fool • Feb 11, 2026

Energy Leads This Year As Tech And Financials Fall Behind
Energy, basic materials, and defensive consumer stocks are in. Tech and financials are out.
Seeking Alpha • Feb 11, 2026

Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and diabetes, outpacing Novo Nordisk, which faces a sharp 2026 revenue decline amid fierce competition, pricing pressure, and other factors.
Seeking Alpha • Feb 7, 2026

ETFs to Play as Investors Chase Diversification Amid Tech Rout
From "software-mageddon" to rising AI capex pressuring Big Tech, diversification via defensive and global ETFs gains focus.
Zacks Investment Research • Feb 6, 2026

Energy Leads S&P Sectors in January
Three of the smallest sectors in the S&P 500 delivered the index's strongest performance in January, while the two largest sectors weighed on returns. The broad market index gained modest ground last month, with the State Street SPDR S&P 500 ETF Trust (SPY) up 0.6%, according to ETF Database.
ETF Trends • Feb 3, 2026

U.S. Consumer Confidence Slumps to Decade Low: ETF Areas to Play
U.S. consumer confidence hits a decade low. Defensive, quality & dividend ETFs like XLP, XLV, XLU, SPHQ & VYM may offer shelter.
Zacks Investment Research • Feb 2, 2026

2 Hot Sector ETFs Worth Buying in 2026
Index investors and so-called Bogleheads (those who love the Vanguard ETFs) may not be all too fond of the sector ETFs, especially when you consider that simply buying the S&P 500 covers most of one's bases when it comes to diversification.
24/7 Wall Street • Jan 29, 2026

3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers
Flat Medicare Advantage rate hikes hit insurers hard, but diversified healthcare ETFs may help investors weather the policy shock.
Zacks Investment Research • Jan 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Health Care Select Sector SPDR Fund commission-free¹. Build wealth for the long term using automated trading and transfers.